Research programme: cell cycle checkpoint activators - ArQuleAlternative Names: ARQ-150RP; ARQ-450RP; ARQ-800RP
Latest Information Update: 11 Apr 2011
At a glance
- Originator ArQule
- Class Small molecules
- Mechanism of Action Checkpoint kinase 2 stimulants; Checkpoint kinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer